Risk Compensation After Initiation of Daily Oral Pre-exposure Prophylaxis Among Sexual and Gender Minorities in Nigeria

被引:0
|
作者
Adeyemi, Olusegun A. [1 ,2 ]
Nowak, Rebecca G. [3 ]
Morgan, Daniel [1 ]
Sam-Agudu, Nadia A. [2 ,3 ]
Craddock, Jaih [4 ]
Zhan, Min [5 ]
Crowell, Trevor A. [6 ,7 ]
Baral, Stefan [8 ]
Adebajo, Sylvia [9 ]
Charurat, Manhattan E. [3 ]
机构
[1] Univ Maryland, Dept Publ Hlth & Epidemiol, Sch Med, 725 West Lombard St,S422, Baltimore, MD 21201 USA
[2] Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria
[3] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD USA
[4] Univ Calif Irvine, Sch Med, Irvine, CA USA
[5] Univ Maryland, Dept Publ Hlth & Epidemiol, Div Biostat & Bioinformat, Sch Med, Baltimore, MD USA
[6] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD USA
[7] US Mil HIV Res Program, Silver Spring, MD USA
[8] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[9] Ctr Int Hlth Educ & Biosecur, Abuja, Nigeria
关键词
Pre-exposure prophylaxis; Sexual and gender minority; Sexually transmitted infections; Risk adjustment behaviors; Sexual orientation; HIV; MEN; PREP; BEHAVIOR; ADHERENCE; MSM;
D O I
10.1007/s10508-024-02859-9
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Pre-exposure prophylaxis (PrEP) use may be associated with risk compensation. We enrolled and provided PreP to sexual and gender minorities (SGM) in Abuja, Nigeria between April 2018 and May 2019. Behavioral information and samples for urogenital and anorectal Chlamydia trachomatis and Neisseria gonorrhoeae sexually transmitted infections (STIs) were collected at baseline. Blood samples for PrEP assay and self-reported adherence were collected at three-monthly follow-up visits. STIs were detected using Aptima Combo2 assay. We estimated the odds ratios (ORs) of PCR-diagnosed bacterial STIs and self-reported behavioral outcomes (condomless anal intercourse [CAI] and concurrent sexual relationships) with conditional logistic regression. Of 400 SGM who initiated PrEP, 206 were eligible for analysis, and had a median age of 24 years (IQR 22-27). In multivariable analysis, participants in the PrEP period had decreased odds of CAI (adjusted OR: 0.49, 95% CI 0.28, 0.84). PrEP use was not associated with risk compensation.
引用
收藏
页码:2807 / 2816
页数:10
相关论文
共 50 条
  • [1] Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV
    Milam, Joel
    Jain, Sonia
    Dube, Michael P.
    Daar, Eric S.
    Sun, Xiaoying
    Corado, Katya
    Ellorin, Eric
    Blumenthal, Jill
    Haubrich, Richard
    Moore, David J.
    Morris, Sheldon R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (01) : E9 - E13
  • [2] Discordance Between HIV Risk Perception, Sexual Behavior, and Pre-exposure Prophylaxis Adherence Among Young Sexual and Gender Minorities in the United States
    Kelly, Nicole K.
    Rosso, Matthew T.
    Rainer, Crissi
    Claude, Kristina
    Muessig, Kathryn E.
    Hightow-Weidman, Lisa
    JOURNAL OF ADOLESCENT HEALTH, 2024, 74 (06) : 1112 - 1117
  • [3] Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil
    Pereira, Claudia Cristina de Aguiar
    Torres, Thiago Silva
    Luz, Paula Mendes
    Hoagland, Brenda
    Farias, Alessandro
    Brito, Jose David Urbaez
    Lacerda, Marcus Vinicius Guimaraes
    Silva, Daila Alena Raenck
    Benedetti, Marcos
    Pimenta, Maria Cristina
    Grinsztejn, Beatriz
    Veloso, Valdilea Goncalves
    LANCET REGIONAL HEALTH-AMERICAS, 2023, 19
  • [4] Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project
    Hoornenborg, Elske
    Coyer, Liza
    van Laarhoven, Anna
    Achterbergh, Roel
    de Vries, Henry
    Prins, Maria
    van der Loeff, Maarten Schim
    AIDS, 2018, 32 (11) : 1527 - 1532
  • [5] Awareness and Knowledge of Pre-exposure Prophylaxis Among Sexual and Gender Minority Adolescents Assigned Male at Birth in the United States
    Matson, Margaret
    Nery-Hurwit, Mara
    Crosby, Shariell
    Greene, George J.
    Macapagal, Kathryn
    ARCHIVES OF SEXUAL BEHAVIOR, 2021, 50 (04) : 1701 - 1711
  • [6] Individual and structural-level Correlates of Pre-exposure Prophylaxis (PrEP) lifetime and current use in a nationwide sample of young sexual and gender minorities
    Fitch, Calvin
    Haberer, Jessica E.
    Serrano, Pedro A.
    Munoz, Alejandro
    French, Audrey L.
    Hosek, Sybil G.
    AIDS AND BEHAVIOR, 2022, 26 (10) : 3365 - 3377
  • [7] Awareness of, willingness to use, and experiences with Pre-exposure prophylaxis among youth in Nigeria
    Gbaja-Biamila, Titilola
    Obiezu-Umeh, Chisom
    Nwaozuru, Ucheoma
    Rosenberg, Nora E.
    Igbokwe, Mesoma
    Oladele, David
    Musa, Adesola Z.
    Idigbe, Ifeoma
    Conserve, Donaldson
    Day, Suzanne
    Tahlil, Kadija
    Ong, Jason
    Muessig, Kathryn
    Nkengasong, Susan
    Xian, Hong
    Tucker, Joseph D.
    Ezechi, Oliver
    Iwelunmor, Juliet
    BMC HEALTH SERVICES RESEARCH, 2024, 24 (01)
  • [8] Determinants of Willingness to Use Oral HIV Pre-Exposure Prophylaxis Among Transgender Women in Colombia
    Alvarado, Beatriz
    Torres, Julian
    Mueses-Marin, Hector Fabio
    Bolivar, Maria Camila
    Camargo-Plazas, Pilar
    Arrivillaga, Marcela
    Gomez, Sheila
    Martinez-Cajas, Jorge Luis
    TRANSGENDER HEALTH, 2025,
  • [9] Determinants of Preexposure Prophylaxis Cascade Among Sexual and Gender Minorities in Nigeria
    Ramadhani, Habib Omari A.
    Crowell, Trevor G.
    Nowak, Rebecca
    Adebajo, Sylvia O.
    Kayode, Blessing
    Ononaku, Uchenna D.
    Baral, Stefan
    Ndembi, Nicaise E.
    Charurat, Man
    SEXUALLY TRANSMITTED DISEASES, 2023, 50 (09) : 559 - 566
  • [10] Sexual Risk Trajectories Among MSM in the United States: Implications for Pre-exposure Prophylaxis Delivery
    Pines, Heather A.
    Gorbach, Pamina M.
    Weiss, Robert E.
    Shoptaw, Steve
    Landovitz, Raphael J.
    Javanbakht, Marjan
    Ostrow, David G.
    Stall, Ron D.
    Plankey, Michael
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (05) : 579 - 586